Kings Path Partners’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.2K Sell
270
-6
-2% -$879 0.01% 186
2026
Q2
$40.5K Buy
276
+6
+2% +$873 0.01% 182
2026
Q1
$39K Hold
270
– – 0.01% 175
2025
Q4
$38.7K Hold
270
– – 0.01% 175
2025
Q3
$41.5K Hold
270
– – 0.02% 174
2025
Q2
$43K Hold
270
– – 0.02% 165
2025
Q1
$46K Hold
270
– – 0.02% 158
2024
Q4
$45.3K Hold
270
– – 0.02% 183
2024
Q3
$46.8K Hold
270
– – 0.02% 184
2024
Q2
$44.5K Buy
+270
New +$44.1K 0.02% 171

Other funds holding PG

Kings Path Partners's PG Position: Q3 2026 in Review

Kings Path Partners reduced its Procter & Gamble (PG) stake by 2.2% in Q3 2026, selling an estimated $879 and leaving 270 shares worth $39.2K. The position accounts for 0.01% of the portfolio, ranked #186.

Kings Path Partners first reported a position in PG in Q2 2024 and has held it in 10 quarters since. The position peaked at $46.8K in Q3 2024. 2,487 funds tracked by Wall St. Rank hold PG as of Q3 2026.

  • Kings Path Partners held 270 shares of Procter & Gamble worth $39.2K as of Q3 2026.
  • Kings Path Partners sold 6 Procter & Gamble shares in Q3 2026, an estimated $879.
  • Procter & Gamble made up 0.01% of Kings Path Partners's portfolio in Q3 2026, its #186 holding.
  • Kings Path Partners first reported a position in Procter & Gamble in Q2 2024 and has held it in 10 quarters since.
  • Kings Path Partners's Procter & Gamble position peaked at $46.8K in Q3 2024.
  • 2,487 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2026.

Based on Kings Path Partners's 13F filing for Q3 2026, filed 21 Oct 2026.